{"id":"https://openalex.org/W2147221452","doi":"https://doi.org/10.3233/hab-2004-13402","title":"Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly","display_name":"Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly","publication_year":2005,"publication_date":"2005-01-22","ids":{"openalex":"https://openalex.org/W2147221452","doi":"https://doi.org/10.3233/hab-2004-13402","mag":"2147221452","pmid":"https://pubmed.ncbi.nlm.nih.gov/15671576"},"language":"en","primary_location":{"id":"doi:10.3233/hab-2004-13402","doi":"https://doi.org/10.3233/hab-2004-13402","is_oa":false,"landing_page_url":"https://doi.org/10.3233/hab-2004-13402","pdf_url":null,"source":{"id":"https://openalex.org/S2764542884","display_name":"Human Antibodies","issn_l":"0956-960X","issn":["0956-960X","1093-2607","1875-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Antibodies","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100455967","display_name":"Fei Wang","orcid":"https://orcid.org/0000-0003-3948-6899","observed_orcids":["https://orcid.org/0000-0003-3948-6899"]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fei Wang","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043058252","display_name":"Paul E. Ruther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Ruther","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028796504","display_name":"Ivy Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivy Jiang","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039066548","display_name":"Ritsuko Sawada-Hirai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritsuko Sawada-Hirai","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110251374","display_name":"Shu Man Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shu Man Sun","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000039237","display_name":"Rebecca Nedellec","orcid":"https://orcid.org/0009-0002-6402-1102","observed_orcids":["https://orcid.org/0009-0002-6402-1102"]},"institutions":[{"id":"https://openalex.org/I123431417","display_name":"Scripps Research Institute","ror":"https://ror.org/02dxx6824","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I123431417"]},{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Nedellec","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","Current affiliation: Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]},{"raw_affiliation_string":"Current affiliation: Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA","institution_ids":["https://openalex.org/I123431417"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Phillip R. Morrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip R. Morrow","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014158535","display_name":"Angray S. Kang","orcid":"https://orcid.org/0000-0002-4672-4114","observed_orcids":["https://orcid.org/0000-0002-4672-4114"]},"institutions":[{"id":"https://openalex.org/I4210127237","display_name":"Avanir Pharmaceuticals (United States)","ror":"https://ror.org/02z28nb98","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127237"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angray S. Kang","raw_affiliation_strings":["Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avanir Pharmaceuticals, Antibody Technology, 11388 Sorrento Valley Rd, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210127237"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.3804,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.78955545,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"13","issue":"4","first_page":"105","last_page":"110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11515","display_name":"Bacillus and Francisella bacterial research","score":0.8740000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11515","display_name":"Bacillus and Francisella bacterial research","score":0.8740000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.09529999643564224,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthrax-toxin","display_name":"anthrax toxin","score":0.921999990940094},{"id":"https://openalex.org/keywords/protective-antigen","display_name":"protective antigen","score":0.9700000286102295},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9539999961853027},{"id":"https://openalex.org/keywords/toxin-neutralization","display_name":"toxin neutralization","score":0.8539999723434448},{"id":"https://openalex.org/keywords/oligomerization-inhibition","display_name":"oligomerization inhibition","score":0.753000020980835},{"id":"https://openalex.org/keywords/epitope-mapping","display_name":"epitope mapping","score":0.6600000262260437},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.6079999804496765},{"id":"https://openalex.org/keywords/anthrax","display_name":"anthrax","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C41810244","wikidata":"https://www.wikidata.org/wiki/Q1935986","display_name":"Anthrax toxin","level":5,"score":0.8600082993507385},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.8543428182601929},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.67557692527771},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6657052040100098},{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.6415960788726807},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6391676664352417},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.634929358959198},{"id":"https://openalex.org/C2780239966","wikidata":"https://www.wikidata.org/wiki/Q614156","display_name":"Bacillus anthracis","level":3,"score":0.5402564406394958},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47623422741889954},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4551903307437897},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.44838380813598633},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.3914330005645752},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36303868889808655},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.16850990056991577},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16608333587646484},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16046258807182312},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.08088091015815735},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0674334168434143},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000080908","descriptor_name":"Broadly Neutralizing Antibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000942","descriptor_name":"Antigens, Bacterial","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001427","descriptor_name":"Bacterial Toxins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004591","descriptor_name":"Electrophoresis, Polyacrylamide Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3233/hab-2004-13402","doi":"https://doi.org/10.3233/hab-2004-13402","is_oa":false,"landing_page_url":"https://doi.org/10.3233/hab-2004-13402","pdf_url":null,"source":{"id":"https://openalex.org/S2764542884","display_name":"Human Antibodies","issn_l":"0956-960X","issn":["0956-960X","1093-2607","1875-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Antibodies","raw_type":"journal-article"},{"id":"pmid:15671576","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15671576","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human antibodies","raw_type":"Journal Article"},{"id":"pmh:oai:westminsterresearch.wmin.ac.uk:1544","doi":null,"is_oa":false,"landing_page_url":"http://westminsterresearch.wmin.ac.uk/1544/1/Wang_Ruther_Jiang_et_al_2004_final.pdf","pdf_url":"http://westminsterresearch.wmin.ac.uk/1544/1/Wang_Ruther_Jiang_et_al_2004_final.pdf","source":{"id":"https://openalex.org/S4306400277","display_name":"WestminsterResearch (University of Westminster)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I94951947","host_organization_name":"University of Westminster","host_organization_lineage":["https://openalex.org/I94951947"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G119112205","display_name":null,"funder_award_id":"R43052901-01A1","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G624065009","display_name":"Human Antibodies for Exposure/Protection from Anthrax","funder_award_id":"1r43ai058458-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7648725415","display_name":null,"funder_award_id":"R43 AI058458-01","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320315425","display_name":"Avanir Pharmaceuticals","ror":"https://ror.org/02z28nb98"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1487527789","https://openalex.org/W1610696702","https://openalex.org/W1765888134","https://openalex.org/W1995910871","https://openalex.org/W2004673387","https://openalex.org/W2059734188","https://openalex.org/W2083670089","https://openalex.org/W2085053769","https://openalex.org/W2089703049","https://openalex.org/W2101355256","https://openalex.org/W2123567281","https://openalex.org/W2125866523","https://openalex.org/W2132058165","https://openalex.org/W2136218146","https://openalex.org/W2142836431","https://openalex.org/W2158990652"],"related_works":["https://openalex.org/W2136218146","https://openalex.org/W7203455000","https://openalex.org/W2111827924","https://openalex.org/W1994513272","https://openalex.org/W2277631876","https://openalex.org/W7095588601","https://openalex.org/W2022712848","https://openalex.org/W2125947940","https://openalex.org/W2401701102","https://openalex.org/W2098012323"],"abstract_inverted_index":{"A":[0],"panel":[1],"of":[2,16,37],"human":[3],"anti-anthrax":[4],"protective":[5,26,48],"antigen":[6,27,49],"IgG1":[7],"monoclonal":[8],"antibodies":[9,39],"were":[10],"evaluated":[11],"to":[12,24,31],"determine":[13],"the":[14,25,38,41,47],"mechanism":[15],"toxin":[17,43],"neutralization.":[18],"AVP-22G12,":[19],"AVP-1C6":[20],"and":[21],"AVP-21D9":[22],"bound":[23],"with":[28],"picomolar":[29],"affinities":[30],"distinct":[32],"non-overlapping":[33],"linear":[34],"epitopes.":[35],"Two":[36],"neutralized":[40],"anthrax":[42],"by":[44],"completely":[45],"inhibiting":[46],"oligomer":[50],"assembly":[51],"process":[52],"in":[53],"vitro.":[54]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}